Caitlin R Hopkins

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Top Venues

Cancer immunology research

Cancer discovery

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Ju-Fang Chang, Nils Wellhausen, Nils Wolfgang Engel, Jack H Landmann, Caitlin R Hopkins, January Salas-McKee, Adham S Bear, Mehmet Emrah Selli, Sangya Agarwal, Julie K Jadlowsky, Gerald P Linette, Saar I Gill, Carl H June, Joseph A Fraietta, Nathan Singh
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors. Cancer immunology research 12 (9) (2024)
Ju-Fang Chang, Nils Wellhausen, Nils Wolfgang Engel, Jack H Landmann, Caitlin R Hopkins, January Salas-McKee, Adham S Bear, Mehmet Emrah Selli, Sangya Agarwal, Julie K Jadlowsky, Gerald P Linette, Saar I Gill, Carl H June, Joseph A Fraietta, Nathan Singh
Identification of core techniques that enhance genome editing of human T cells expressing synthetic antigen receptors. Cancer immunology research (2024)
In-Young Jung, Robert L Bartoszek, Andrew J Rech, Sierra M Collins, Soon-Keat Ooi, Erik F Williams, Caitlin R Hopkins, Vivek Narayan, Naomi B Haas, Noelle V Frey, Elizabeth O Hexner, Donald L Siegel, Gabriela Plesa, David L Porter, Vito Adrian Cantu, John K Everett, Sonia Guedan, Shelley L Berger, Frederic D Bushman, Friederike Herbst, Joseph A Fraietta
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T cell-intrinsic Dysfunction. Cancer discovery (2023)
Connor A Tsuchida, Nadav Brandes, Raymund Bueno, Marena I Trinidad, Thomas Mazumder, Bingfei Yu, Byungjin Hwang, Christopher Chang, Jamin Liu, Yang Sun, Caitlin R Hopkins, Kevin R Parker, Yanyan Qi, Ansuman T Satpathy, Edward A Stadtmauer, Jamie H D Cate, Justin Eyquem, Joseph A Fraietta, Carl H June, Howard Y Chang, Chun Jimmie Ye, Jennifer A Doudna
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells. bioRxiv : the preprint server for biology (2023)